Skip to main content
TipRanks
Go Ultimate75% OFF

Apex Biotechnology Corp. (1733) Cash flow

Apex Biotechnology Corp. Cash Flow

TW:1733's free cash flow for Q2 2026 was NT$161.49M. For the 2026 fiscal year, TW:1733's free cash flow was decreased by NT$-2.79M and operating cash flow was NT$164.28M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 164.14MNT$ 328.67MNT$ 230.39MNT$ 26.62MNT$ 179.87M
NT$ -5.54MNT$ -35.60MNT$ -22.50MNT$ -41.37MNT$ -35.02M
NT$ -132.68MNT$ -148.67MNT$ -168.14MNT$ -237.60MNT$ -351.27M
NT$ 567.09MNT$ 532.68MNT$ 382.05MNT$ 331.70MNT$ 555.33M
NT$ 148.88MNT$ 299.04MNT$ 205.41MNT$ -13.58MNT$ 153.67M

Currency in TWD

Apex Biotechnology Corp. Cash Flow

-400M-200M0200M400M600M201720182019202020212022202320242025OperatingInvestingFinancing